Hexarelin // Strongest Single-Dose GHRP
The most potent single-dose GH releasing peptide ever developed. Hexarelin produces the highest GH spike of any GHRP — but with a critical limitation: rapid receptor desensitization. After 4–8 weeks of continuous use, the GH response diminishes significantly. This makes Hexarelin a burst-cycle tool, not a long-term protocol.
Maximum pulse. Limited window.
Hexarelin is the most potent GHRP at stimulating acute GH release — producing GH spikes reportedly 15–20x baseline. It achieves this through aggressive ghrelin receptor activation with additional direct effects on cardiac tissue. However, the very potency that makes it remarkable also causes its primary limitation: the ghrelin receptor desensitizes after 4–8 weeks of continuous use, reducing the GH response to near-baseline levels.
Burst protocols only. The receptor demands it.
Hexarelin requires a fundamentally different approach than other GHRPs. It's not a long-term protocol — it's a burst tool. Run it for 4–8 weeks at 100–200mcg per dose 1–3x daily, then take an equal break to restore receptor sensitivity. Exceeding 200mcg per dose doesn't increase GH output but does increase side effects. The burst approach actually yields more total GH over time than trying to run it continuously.
The peak that couldn't be sustained.
Hexarelin (Examorelin) was developed as part of the GHRP research program and identified as the most potent member of the class for acute GH stimulation. Studies showed GH release reaching 15–20x baseline levels — exceeding GHRP-2, GHRP-6, and all other synthetic ghrelin mimetics.
The desensitization phenomenon was well-documented in clinical studies: subjects receiving continuous hexarelin showed progressive decline in GH response beginning at 4–6 weeks, with significant attenuation by 8–12 weeks. This receptor downregulation is reversible — sensitivity returns after a washout period of equivalent duration.
Hexarelin's unique cardioprotective profile has attracted research interest beyond GH secretion. Studies demonstrate binding to cardiac CD36 receptors with anti-ischemic, anti-fibrotic, and cardioprotective properties. This makes it pharmacologically distinct from other GHRPs, though clinical application of the cardiac effects remains investigational.
Hexarelin vs. sustainable GHRPs.
| Compound | Peak GH | Sustainable? | Side Effects | Best Use |
|---|---|---|---|---|
| Ipamorelin | ~5x baseline | Yes (months) | Minimal | Long-term base |
| GHRP-2 | ~10x baseline | Yes (12–16 wk) | Moderate | Balanced output |
| Hexarelin | ~15–20x baseline | No (4–8 wk max) | Significant | Burst cycles |
| GHRP-6 | ~10x baseline | Yes (8–12 wk) | Significant + hunger | Bulking |
What to watch for.
Hexarelin's side effect profile is manageable with proper protocol adherence. Baseline blood work before starting and periodic monitoring during use is essential.
- Cortisol elevation (significant — similar to GHRP-2)
- Prolactin elevation (significant at higher doses)
- Receptor desensitization (the primary limitation — 4–8 week window)
- Water retention
- Flushing and warmth
- Tingling in extremities
- Moderate appetite stimulation (less than GHRP-6)
- Potential cardiac effects (generally considered beneficial)
- IGF-1 (track decline to detect desensitization)
- Cortisol (morning draw — critical to monitor)
- Prolactin (baseline + 4 weeks)
- Fasting glucose and insulin
- Thyroid panel
- Cardiac markers (CRP, BNP) if cardiac effects are a focus
- CBC and CMP
- GH stimulation response (to confirm desensitization timing)
- ALWAYS combine with a GHRH analog during burst phase
- Transition to Ipamorelin during washout periods
- BPC-157 for recovery support
- Do NOT run continuously beyond 8 weeks
- Do NOT combine with other GHRPs during burst phase
- Do NOT increase dose above 200mcg — it doesn't help
- Lyophilized: refrigerate at 2–8°C (36–46°F)
- Reconstituted: refrigerate, use within 28 days
- Protect from light and heat
- Do not freeze reconstituted solution
- Stable peptide with standard storage requirements
- Research grade: confirm ≥98% HPLC purity on COA
Compounds that complement Hexarelin.
The nuclear option — powerful but self-limiting.
Hexarelin is the most potent GHRP ever developed. If your goal is the absolute maximum GH pulse possible from a secretagogue, this is the tool — for 4–8 weeks. After that, receptor desensitization makes it progressively useless. The smart approach: run burst cycles of Hexarelin + CJC-1295 for 4–8 weeks, then switch to Ipamorelin + CJC-1295 for the washout period, and repeat. This cycling strategy delivers more total GH over time than any single-compound protocol. Monitor cortisol and prolactin, never exceed 200mcg per dose, and respect the desensitization window.
Our free Protocol Guide includes Hexarelin burst cycling, washout strategies, IGF-1 tracking, and blood work panels.